Literature DB >> 15225667

Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits.

E M Ammar1, Shehta A Said, Mohammed S Hassan.   

Abstract

Androgenic-anabolic steroids (AAS) are widely abused by athletes and this abuse has been associated with many serious circulatory events including sudden cardiac death, myocardial infarction and cardiac hypertrophy. The effect of chronic treatment for 16 weeks with testosterone (25mg(-1)kg(-1)week(-1)) and nandrolone (50mg(-1)kg(-1)week(-1)) on serum lipids of male hypercholesterolemic New Zealand rabbits was investigated. The responses of isolated rabbit aortic rings to some vasoconstrictors (epinephrine, serotonin and endothelin-1) and vasodilators (adenosine and sodium nitroprusside) were also measured after treatment. Testosterone and nandrolone significantly reduced HDL-cholesterol levels, potentiated vasoconstriction responses to epinephrine, serotonin and endothelin-1, and attenuated vasorelaxant responses to sodium nitroprusside in rabbits. Nandrolone also caused a significant increase in LDL-cholesterol levels. No significant changes in adenosine relaxation were found in rabbits. The results of the present study showed that the abuse of AAS in presence of hypercholesterolemia can enhance atherogenicity and vasospasm as well as attenuation of vasorelaxation. Therefore the abuse of AAS is harmful to the vascular system and should be prohibited.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225667     DOI: 10.1016/j.phrs.2004.03.010

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  19 in total

1.  Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.

Authors:  O Moran; L J V Galietta; O Zegarra-Moran
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

2.  Antiandrogen pretreatment alters cocaine pharmacokinetics in men.

Authors:  Rinah T Yamamoto; Christian J Teter; Tanya L Barros; Elissa McCarthy; Crystal Mileti; Trisha Juliano; Carissa L Medeiros; Alison Looby; Melissa A Maywalt; Jane F McNeil; David Olson; Gopinath Mallya; Scott E Lukas; Perry F Renshaw; Marc J Kaufman
Journal:  J Addict Med       Date:  2007-12       Impact factor: 3.702

Review 3.  [Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer : Differences between GnRH antagonists and GnRH agonists].

Authors:  C Tschöpe; B Kherad; F Spillmann; C A Schneider; B Pieske; F Krackhardt
Journal:  Herz       Date:  2016-04-15       Impact factor: 1.443

4.  Blood pressure and mesenteric vascular reactivity in spontaneously hypertensive rats 7 months after gonadectomy.

Authors:  Rabelais Tatchum-Talom; Kathleen M Eyster; Curtis K Kost; Douglas S Martin
Journal:  J Cardiovasc Pharmacol       Date:  2011-03       Impact factor: 3.105

Review 5.  Anabolic steroids and cardiovascular risk.

Authors:  Peter Angell; Neil Chester; Danny Green; John Somauroo; Greg Whyte; Keith George
Journal:  Sports Med       Date:  2012-02-01       Impact factor: 11.136

6.  Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.

Authors:  Brian L Stauffer; Christian M Westby; Jared J Greiner; Gary P Van Guilder; Christopher A Desouza
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-25       Impact factor: 3.619

Review 7.  [Cardiovascular risk patients under androgen deprivation therapy: Lower risk with GnRH antagonists compared to LHRH agonists?].

Authors:  Axel S Merseburger; Daniel Sedding; Kai Hüter
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

8.  Renal phenotype of ET-1 transgenic mice is modulated by androgens.

Authors:  P Kalk; C Thöne-Reineke; A Schwarz; M Godes; C Bauer; T Pfab; B Hocher
Journal:  Eur J Med Res       Date:  2009       Impact factor: 2.175

Review 9.  Testosterone and the cardiovascular system: a comprehensive review of the basic science literature.

Authors:  Michael J Herring; Peyman Mesbah Oskui; Sharon L Hale; Robert A Kloner
Journal:  J Am Heart Assoc       Date:  2013-07-10       Impact factor: 5.501

Review 10.  Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome.

Authors:  I-Chen Yu; Hung-Yun Lin; Janet D Sparks; Shuyuan Yeh; Chawnshang Chang
Journal:  Diabetes       Date:  2014-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.